Evaluation of Sleep Quality in Prostate Cancer Patients Undergoing Treatment With Hormonal Therapeutic Approaches and in Patients With Full-resected Early Breast Cancer
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This study will use polysomnography, alongside other methodologies such as questionnaires, actigraphic measurements and salivary melatonin samples used in previous studies to investigate sleep quality in patients with i) localized, locally advanced or metastatic hormone sensitive prostate cancer or ii) with full-resected early (stage I-III) epithelial breast cancer. The measurements will be taken before androgen deprivation therapy (ADT - for prostate cancer patients) or endocrine therapy (for breast cancer patients) is initiated, at 6 months and some measures again at 12 months.The groups, defined by cancer type and whether or not treatment includes ADT / endocrine therapy, will be compared to see if there are differences in the prevalence of the lowered sleep quality in the groups.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Pisemna zgoda na uczestnictwo w badaniu
- •Potwierdzony nowotwór gruczołu krokowego (rak prostaty)
- •Dobry ogólny stan zdrowia (ocena 0-2)
- •Mężczyzna powyżej 18 lat
- •Rak prostaty wrażliwy na hormony (na wczesnym, zaawansowanym lub rozsianym stadium)
- •Wymagane rozpoczęcie leczenia hormonalnego (ADT) jako standard opieki
- •Planowane leczenie hormonalne przez co najmniej 6 miesięcy, ewentualnie w połączeniu z radioterapią
✗ Disqualifies
- •Rak prostaty typu drobnokomórkowego
- •Wcześniejsze leczenie hormonalne lub lekami hormonalnymi
- •Leczenie innego nowotworu w ostatnich 12 miesiącach
- •Aktywny drugi nowotwór wymagający leczenia
- •Bezwzględne przeciwwskazania do leczenia hormonalnego
- •Bezdechy senne (zespół bezdechu podczas snu)
- •Znaczna nadwaga (BMI powyżej 35)
- •Poważne choroby układu oddechowego lub serca w ostatnich 6 miesiącach
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- November 18, 2025
- Sex
- No restrictions
Therapies / drugs in trial
Locations (1)
IOSI
Bellinzona, Switzerland
Trial contact
Ursula Vogl, MD
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/1/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.